vs

Side-by-side financial comparison of Amer Sports, Inc. (AS) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Amer Sports, Inc. is the larger business by last-quarter revenue ($1.1B vs $719.4M, roughly 1.5× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 1.8%, a 71.4% gap on every dollar of revenue. Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $92.2M).

Amer Sports, Inc. is a Finnish multinational sporting equipment division based in Helsinki, Finland. Established in 1950 as an industrial conglomerate with interests as diverse as tobacco trading, ship owning and publishing, Amer has gradually evolved into a multinational firm devoted to the production and marketing of sporting goods. The company employs over 9,700 people. Since 2018, Amer has been a subsidiary of Chinese retail conglomerate Anta Sports.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

AS vs DOC — Head-to-Head

Bigger by revenue
AS
AS
1.5× larger
AS
$1.1B
$719.4M
DOC
Higher net margin
DOC
DOC
71.4% more per $
DOC
73.2%
1.8%
AS
More free cash flow
DOC
DOC
$264.8M more FCF
DOC
$357.0M
$92.2M
AS

Income Statement — Q1 FY2024 vs Q4 FY2025

Metric
AS
AS
DOC
DOC
Revenue
$1.1B
$719.4M
Net Profit
$19.0M
$114.0M
Gross Margin
52.8%
Operating Margin
12.4%
17.4%
Net Margin
1.8%
73.2%
Revenue YoY
3.1%
Net Profit YoY
2406.4%
EPS (diluted)
$0.05
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AS
AS
DOC
DOC
Q4 25
$719.4M
Q3 25
$705.9M
Q2 25
$694.3M
Q1 25
$702.9M
Q4 24
$698.0M
Q3 24
$700.4M
Q2 24
$695.5M
Q1 24
$1.1B
$606.6M
Net Profit
AS
AS
DOC
DOC
Q4 25
$114.0M
Q3 25
$-117.1M
Q2 25
$31.7M
Q1 25
$42.8M
Q4 24
$4.5M
Q3 24
$85.9M
Q2 24
$146.0M
Q1 24
$19.0M
$6.7M
Gross Margin
AS
AS
DOC
DOC
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Q1 24
52.8%
59.8%
Operating Margin
AS
AS
DOC
DOC
Q4 25
17.4%
Q3 25
9.2%
Q2 25
5.7%
Q1 25
7.7%
Q4 24
-2.2%
Q3 24
14.1%
Q2 24
22.3%
Q1 24
12.4%
3.7%
Net Margin
AS
AS
DOC
DOC
Q4 25
73.2%
Q3 25
-16.6%
Q2 25
4.6%
Q1 25
6.1%
Q4 24
0.7%
Q3 24
12.3%
Q2 24
21.0%
Q1 24
1.8%
1.1%
EPS (diluted)
AS
AS
DOC
DOC
Q4 25
$0.16
Q3 25
$-0.17
Q2 25
$0.05
Q1 25
$0.06
Q4 24
$0.02
Q3 24
$0.12
Q2 24
$0.21
Q1 24
$0.05
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AS
AS
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$7.5B
Total Assets
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AS
AS
DOC
DOC
Q4 25
$467.5M
Q3 25
$91.0M
Q2 25
$89.4M
Q1 25
$70.6M
Q4 24
$119.8M
Q3 24
$180.4M
Q2 24
$106.9M
Q1 24
$101.8M
Total Debt
AS
AS
DOC
DOC
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Q1 24
$8.8B
Stockholders' Equity
AS
AS
DOC
DOC
Q4 25
$7.5B
Q3 25
$7.6B
Q2 25
$7.9B
Q1 25
$8.2B
Q4 24
$8.4B
Q3 24
$8.6B
Q2 24
$8.8B
Q1 24
$8.9B
Total Assets
AS
AS
DOC
DOC
Q4 25
$20.3B
Q3 25
$19.6B
Q2 25
$19.8B
Q1 25
$19.8B
Q4 24
$19.9B
Q3 24
$20.0B
Q2 24
$20.2B
Q1 24
$20.5B
Debt / Equity
AS
AS
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AS
AS
DOC
DOC
Operating Cash FlowLast quarter
$114.3M
$1.3B
Free Cash FlowOCF − Capex
$92.2M
$357.0M
FCF MarginFCF / Revenue
8.8%
49.6%
Capex IntensityCapex / Revenue
2.1%
124.4%
Cash ConversionOCF / Net Profit
6.02×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AS
AS
DOC
DOC
Q4 25
$1.3B
Q3 25
$315.0M
Q2 25
$363.5M
Q1 25
$279.4M
Q4 24
$1.1B
Q3 24
$318.2M
Q2 24
$316.2M
Q1 24
$114.3M
$152.6M
Free Cash Flow
AS
AS
DOC
DOC
Q4 25
$357.0M
Q3 25
Q2 25
Q1 25
Q4 24
$333.7M
Q3 24
Q2 24
Q1 24
$92.2M
FCF Margin
AS
AS
DOC
DOC
Q4 25
49.6%
Q3 25
Q2 25
Q1 25
Q4 24
47.8%
Q3 24
Q2 24
Q1 24
8.8%
Capex Intensity
AS
AS
DOC
DOC
Q4 25
124.4%
Q3 25
Q2 25
Q1 25
Q4 24
105.6%
Q3 24
Q2 24
Q1 24
2.1%
Cash Conversion
AS
AS
DOC
DOC
Q4 25
10.99×
Q3 25
Q2 25
11.48×
Q1 25
6.52×
Q4 24
235.43×
Q3 24
3.71×
Q2 24
2.17×
Q1 24
6.02×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AS
AS

Americas2$409.6M39%
EMEA1$356.9M34%
Greater China3$205.6M20%
Asia Pacific4$78.2M7%

DOC
DOC

Segment breakdown not available.

Related Comparisons